Drug Profile
HPP 971
Alternative Names: ANT-401; HPP971Latest Information Update: 28 Jan 2024
Price :
$50
*
At a glance
- Originator vTv Therapeutics LLC
- Developer Anteris Bio; vTv Therapeutics LLC
- Class Anti-inflammatories; Hepatoprotectants; Small molecules
- Mechanism of Action BACH1 protein inhibitors; NF E2 related factor 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Kidney disorders
- No development reported Inflammation; Non-alcoholic steatohepatitis